๐ฐ Eligo Bioscience News
Page 5 - Eligo Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eligo Bioscience. Real-time updates on events, politics, business and more.
April 7, 2021
Bacteriophage to the Future: Insights from the 3rd Bacteriophage Therapy Summit Bacteriophages infecting bacteria (illustration) [Christoph Burgstedt/Science Photo Library/Getty Images] The overuse of broad-spectrum antibiotics has led to the development of multi-resistant bacterial strains, rendering antibiotics useless in the treatment of many infectious diseases. As bacteriophages have re-emerged in recent times and the potential of phage or phage-derived products being used in a clinical se...
February 22, 2021
4 Bacteriophages therapy marketย is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 140.76 million and grow at a CAGR of 16.76% in the above-mentioned forecast period. Increasing prevalence of drug-resistant infections drives the bacteriophages therapy market. Bacteriophages Therapy report provides the solid foundation required to accomplish the variety of business challenges that come...
February 8, 2021
This market study on Bacteriophages Therapy Market covers The market study conducted in this report analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors in the industry. Also, it sheds light on the wide-ranging competitive landscape of the global Bacteriophages Therapy market. It defines about the recent innovations, applications and end users of the market.The report first...
January 28, 2021
Share this article Share this article ResearchAndMarkets.coms offering. Antimicrobial Resistance is creating new kinds of infections and "superbugs" that are resistant to current antibiotic medicines. New technologies (and new drugs) are under development to capture this growing market. We have identified the 6 Key Large Opportunities in this space and developed market forecasts.The publisher has looked at the technology picture too, giving you, plain language understanding of the different wa...
January 21, 2021
British pharma company GlaxoSmithKline (GSK) are to pair up with Eligo Bioscience in a deal potentially worth โฌ185m ($224m) that sees the firms target the microbiome to reduce the risk of developing acne. The agreement terms provide Eligo with an upfront payment along with R&D funding to develop EB005, the Paris-based firmโs discovery program for acne, until preclinical proof of concept. Here, GSK could form a license and collaboration deal with Eligo to further ...
January 13, 2021
Seventure Partners has been investing in microbiome innovation since the launch of its 2014 Health for Life Fund and will now extend reach of its latest fund due to so much interest (Getty Images) European life sciences investment firm Seventure Partners has extended the final close of its second microbiome innovation fund and increased focus on advances in the skin microbiome space. Seventure Partners had been investing in microbiome innovation since the launch of i...